CHRONIC SPONTANEOUS URTICARIA (CSU)
Clinical trials for CHRONIC SPONTANEOUS URTICARIA (CSU) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC SPONTANEOUS URTICARIA (CSU) trials appear
Sign up with your email to follow new studies for CHRONIC SPONTANEOUS URTICARIA (CSU), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race for faster hives relief: new pill takes on established shot
Disease control Recruiting nowThis study is testing if a new oral medication called remibrutinib works faster than an existing injectable drug, dupilumab, to control chronic hives. It will involve about 400 US adults whose hives and itching are not controlled by standard allergy pills. Participants will take …
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Cheaper copycat drug put to the test: does it work as well?
Disease control Recruiting nowThis study is observing patients who are already doing well on a specific biologic drug for severe asthma or chronic hives. Their doctors have decided to switch them to a new, similar version called a biosimilar. The main goal is to see if patients remain well-controlled and sati…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Sponsor: Celltrion HealthCare France • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Scientists dig into the building blocks of allergies
Knowledge-focused Recruiting nowThis study aims to learn how different versions of a protein called IgE are involved in various allergic conditions. Researchers will compare samples from 200 adults, including people with allergies, severe reactions, and healthy volunteers. The goal is to gather knowledge that c…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Sponsor: KU Leuven • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC